To better equip doctors with critical information related to blood clots in patients, Abbott created the Ultreon 1.0 Software, the first of its kind. The Ultreon 1.0 Software gives doctors enhanced ...
Abbott Laboratories ABT recently received the FDA go-ahead for its latest optical coherence tomography (OCT) imaging platform, powered by the company's new Ultreon Software. The Ultreon Software is a ...
Abbott Laboratories has secured FDA clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company’s new Ultreon software. The artificial intelligence (AI)-powered ...
- Ultreon™ 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using Artificial Intelligence - The new intuitive interface provides ...
Abbott landed FDA clearance for its imaging software, which employs artificial intelligence to give doctors a clearer look at blood flow and blockages in heart vessels. The Ultreon 1.0 Software pairs ...
CHENNAI: Kauvery Heart Institute, the centre of excellence in comprehensive cardiac services at Kauvery Hospital – Kovilambakkam, announces the launch of the latest AI-based Ultreon Coronary Imaging ...
The FDA has approved an artificial intelligence-based imaging software developed by Abbott that is used to help physicians carry out procedures like implanting stents to open up narrowed blood vessels ...
- New imaging platform merges optical coherence tomography (OCT) with the power of automation using artificial intelligence (AI) - Ultreon 1.0 Software helps physicians automatically detect and ...
RBI likely to keep repo rate unchanged at 5.25%, maintain neutral stance in April MPC: BoB Report ...
Abbott Laboratories ABT recently received the FDA go-ahead for its latest optical coherence tomography (OCT) imaging platform, powered by the company's new Ultreon Software. The Ultreon Software is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results